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Background: Chronic nonspeciﬁc symptoms attributed to indoor nonindustrial work environments are
common and may cause disability, but the medical nature of this disability is unclear. The aim was to
medically characterize the disability manifested by chronic, recurrent symptoms and restrictions to work
participation attributed to low-level indoor pollutants at workplace and whether the condition shares
features with idiopathic environmental intolerance.
Methods: We investigated 12 patients with indoor airerelated work disability. The examinations
included somatic, psychological, and psychiatric evaluations as well as investigations of the autonomic
nervous system, cortisol measurements, lung function, and allergy tests. We evaluated well-being,
health, disability, insomnia, pain, anxiety, depression, and burnout via questionnaires.
Results: The mean symptom history was 10.5 years; for disabling symptoms, 2.7 years. Eleven patients
reported reactions triggered mainly by indoor molds, one by fragrances only. Ten reported sensitivity to
odorous chemicals, and three, electric devices. Nearly all had co-occurrent somatic and psychiatric
diagnoses and signs of pain, insomnia, burnout, and/or elevated sympathetic responses. Avoiding certain
environments had led to restrictions in several life areas. On self-assessment scales, disability showed
higher severity and anxiety showed lower severity than in physician assessments.
Conclusion: No medical cause was found to explain the disability. Findings support that the condition is a
form of idiopathic environmental intolerance and belongs to functional somatic syndromes. Instead of
endless avoidance, rehabilitation approaches of functional somatic syndromes are applicable.
 2019 Occupational Safety and Health Research Institute, Published by Elsevier Korea LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nonspeciﬁc symptoms attributed to indoor nonindustrial work
environments are common [1]. This kind of ill health varies from
annoyance to functional restrictions in daily life, with no objective
medical ﬁndings to explain the wide symptomatology and
disability [2e5]. Symptomatic individuals try to avoid exposure and
environments that evoke symptoms [6,7].
Although recognized, disability due to indoor environment is
poorly understood from a medical perspective. The term sicktional Health, Topeliuksenkatu 41
afety and Health Research Institute
c-nd/4.0/).building syndrome, launched by the World Health Organization
(WHO) in 1983 [8], describes symptoms at the group level [9] but
does not explain the chronic disability of individuals. Sick building
syndrome includes transient symptoms of a multifactorial origin
which may have a possible relation to indoor pollutants [9]. How-
ever, despite improvements to indoor air quality, chronic respon-
siveness to indoor pollutants may still develop and eventually lead
to disability [2,5,10]. The dilemma is whether the disability is due to
exposure or to increased responsiveness in these individuals [7].b, 00250 Helsinki, Finland.
, Published by Elsevier Korea LLC. This is an open access article under the CC BY-NC-
Table 1
Assessment and evaluation methods
Occupational and psychosocial functioning
Self-assessed current work abilitya [26] Q
Own prognosis regarding being able to work two years from nowb [26] Q
The Social and Occupational Functioning Assessment Scalec [27] I
Sheehan Disability Scale, subdomains work, social life, homed [28] Q
Shirom-Melamed Burnout Measuree [29] Q
Respiratory functioning, inﬂammation, and allergy
Peak Expiratory Flow monitoring for two weeks [30] M
Flow-volume spirometry (Spirostar USB Medikro, Finland) M
Exhaled lower respiratory nitric oxide and nasal nitric oxide [31] M
Bronchial hyperresponsiveness [32] M
Skin prick tests to common environmental allergens and molds (ALK-
Abello, Hørsholm, Denmark; Stallergenes SA, Antony, France)
M
Asthma Control Test (ACT)f [33] Q
Autonomic nervous system function and hypothalamicepituitaryeadrenal axis
functioning
Cardiovascular tests [34e36] M
Hyperventilation provocation test [37] M
Long-term recording of heart rate variability in beat-to-beat intervals
[38,39]
M
Salivary cortisol (LIA, IBL Hamburg, Germany) [40] M
Psychiatric symptoms and functioning and personality
Structured Clinical Interview for DSM-IV Disorders (I and II) [41] I
Yale-Brown Obsessive Compulsive Scale [42] I
MontgomeryeÅsberg Depression Rating Scale [43] I
Generalized Anxiety Disorder 7-item Scale [44] Q
Beck Anxiety Inventory [45] Q
Overall Anxiety Severity and Impairment Scale [46] Q
The Patient Health Questionnaire-9 [47] Q
Beck Depression Inventory [48,49] Q
Insomnia Severity Index [50] Q
Other characteristics
Demographics (e.g. age, gender, marital status, education, work, sick
leave)
I þ Q
Health condition, current symptoms, pain, diseases, medication I þ Q
The Quick Environmental Exposure and Sensitivity Inventory [51]
Chemical Intoleranceg, Life impacth Q
Intolerance to indoor air moldsg, intolerance to electromagnetic ﬁeldsg Q
Environmental-related health concernsi Q
Indoor air quality at workplace and home I þ Q
I, interview; M, medical investigation; Q, questionnaire.
a Scale from 0 (total work disability) to 10 (work ability at its best).
b Options “fairly sure”, “not sure”, or “hardly”.
c Scale 1e100: 51e70 (moderate or some difﬁculty), 71e80 (slight impairment),
81e100 (good or superior functioning).
d Each subdomain on a scale 0e10: 0 (not at all disability), 1e3 (mildly), 4e6
(moderately), 7e9 (markedly), 10 (extremely).
e Mean of the 14 items, each item on a scale 1e7: 1 (never or almost never), 2
(very infrequently), 3 (quite infrequently), 4 (sometimes), 5 (quite frequently), 6
(very frequently), 7 (always or almost always).
f The Finnish version of the ACT. The ACT is a trademark of Quality Metric
Incorporated 2002 GlaxoSmithKline.
g Each item on a scale 0e10: 0 (not at all a problem), 5 (moderate symptoms), 10
(disabling symptoms).
h Each item on a scale 0e10: 0 (not at all), 5 (moderately), 10 (severely).
i Scale from 0 (not at all concern) to 10 (extremely concern).
A. Vuokko et al / Disability Related to Indoor Air 363Increased responsiveness seems to be the mechanism for idio-
pathic environmental intolerance (IEI) [11,12], which describes
reactivity to any environmental factors at levels with no harmful
health effects [13]. Multiple chemical sensitivity (MCS) and hy-
persensitivity to electromagnetic ﬁelds (EMFs) are themost studied
aspects of IEI, and increasing evidence shows that the condition is
not explained by exposures [14,15]. In IEI, the mechanisms involve
reactions due to negative expectancy, i.e. nocebo effects [11].
Multiple criteria have been developed to deﬁne IEI as an ac-
quired chronic condition of multiple, recurring, nonspeciﬁc symp-
toms that are attributed to environmental factors without medical
explanation [13,16]. According to Lacour et al. [17], MCS/IEI criteria
should include signiﬁcant lifestyle or functional impairments, and
thus be limited to severe cases. The criteria remain descriptive, and
the recognition of IEI is based on subjective symptom reporting
without objective ﬁndings or diagnostic tests [18].
Epidemiological studies have estimated the prevalence of
functional restrictions related to IEI [19,20]. In a Danish general
population, 3.3% reported making adjustments to their social lives
or occupational conditions due to chemical intolerance [19]. In a
sample of fertile-aged pregnant women, 2.2% reported behavioral
changes and severe difﬁculties at work, in household re-
sponsibilities, or in their social lives due to intolerance of chemicals,
indoor molds, or EMFs [20].
So far, clinical descriptions of disability have mainly been due to
MCS. One qualitative study showed the nature of disability causes
restraints in lifestyle, social life, and occupational conditions [6].
The clinical evaluation of MCS patients has shown co-occurrence
with psychiatric disorders [21,22], somatic diseases such as
asthma [22], and functional somatic syndromes (FSSs) [23].
Clinical studies characterizing chronic nonspeciﬁc indoor air-
related illness and disability are scarce. Follow-up studies show
that chronic symptomatologies may reduce the quality of life and
social and work functioning [2,3,24]. Applying a qualitative
approach has shown that disability affects several aspects of daily
life, resulting in alterations, limitations, and emotional conse-
quences for individuals [10]. In our previous clinical study, patients
presenting with symptoms due to indoor air and work disability
had long-lasting multiple organ system symptoms that were not
explained by asthma, allergy, or other somatic diseases [5]. More
than half had concerns about a serious disease or loss of health due
to indoor air [5]. The aforementioned study [5] and a similar patient
series [25] found that asthma or asthma-like persisting symptoms
previously attributed to mold were not explained by current
exposure.
The purpose of the present study was a more thorough clinical
evaluation of the medical cause of disability. The aim was to eval-
uate patients with chronic responsiveness to workplace indoor air,
which had interfered with work participation. We clinically studied
the medical cause of the chronic symptoms and activity limitations
related to indoor air and whether the condition fulﬁlled the criteria
of IEI. The goal of this thorough clinical characterization of disability
was to improve the targeting of aid and support to these patients.
2. Materials and methods
2.1. Study population
The participants were 12 patients referred from their occupa-
tional health service (OHS) units to the occupational clinic of the
Finnish Institute of Occupational Health (FIOH) for clinical evalua-
tion. All patients had responsiveness to factors in nonindustrial
workplace indoor air. This had led to disability, whichmanifested as
functional restrictions to avoid the symptoms, and had interfered
with work participation (e.g. inability to work), despiteadjustments to occupational facilities. The referring physician had
failed to ﬁnd a solution to manage the patient’s ill health and work
disability, and had eliminated obvious medical reasons for symp-
toms. All the recruited patients between June 2015 and November
2015 agreed to participate in the study. At study intake, the con-
dition of all the patients suggested features of IEI.
This study was carried out in collaboration with FIOH and Hel-
sinki University Central Hospital.
2.2. Clinical investigations and patient characteristics
Our clinical examinations included systematic evaluations by a
specialist in occupational medicine, a pulmonologist, a psychiatrist,
and a psychologist. The clinical evaluation was based on structured
clinical interviews and questionnaires, as well as on previous
medical records and data on indoor quality and pollutants in the
work environment from a referring OHS’s physician. Investigations
Saf Health Work 2019;10:362e369364of the autonomic nervous system (ANS), hypothalamicepituitarye
adrenal (HPA) axis functioning, lung function, and allergy tests
were included. Patients completed the questionnaires before the
clinical sessions, so that the self-assessments could be utilized in
the clinical evaluation. Finally, our multidisciplinary team assem-
bled conclusions for an individual treatment and rehabilitation
plan, which will be reported in a future paper. Table 1 shows the
description of the assessment methods for the results reported in
this paper. All the other methods used in the clinical evaluation are
shown in supplementary material (Table A.1).
2.2.1. Self-rated assessments
Questionnaires were used to evaluate well-being, health,
disability, insomnia, pain, and distress of anxiety, depression, and
burnout (Table 1). Multisitemusculoskeletal painwas deﬁned using
three questions: (i) “Have you recently experienced aches or
pains?” (yes/no); (ii) “If yes, where on the body have the pains
been?” with options “yes” or “no” for each 16 areas of the body
(head, neck, upper back, shoulder, brachium, forearm, arm, wrist,
hand, lower back, hip, thigh, knee, leg, ankle, and foot); and (iii)
“Have the pains continued over three months?” (yes/no). Only pain
over three months and in at least three different areas of the body
was taken in consideration.
The self-reported functional measure, the Sheehan Disability
Scale (SDS), rated functional impairments in three subdomains
(work, social life, home) [28] (Table 1).
From the chemical intolerance screening instrument, the Quick
Environmental Exposure and Sensitivity Inventory (QEESI), we
used the Chemical Intolerance (CI) and the Life Impact scales [51].
In addition to these, we elicited self-rated intolerance to indoor air
molds in moisture-damaged buildings and intolerance to EMFs
(Table 1). We also inquired about health concerns regarding envi-
ronmental exposures and indoor air exposures at the workplace.
2.2.2. Clinical evaluation
The somatic evaluation was conducted using structured inter-
view material (in Finnish, available by request). We elicited the
patients’ health condition and diseases, symptom proﬁle and
course of illness, occupational and social functioning, as well as
prior adjustments at work and in social life. We also determined the
onset time of symptoms extending to the disabling level and
involving multiple organ systems. The symptoms were divided into
the following symptom groups: central nervous system (CNS),
respiratory or mucosal, dermal, musculoskeletal, cardiac, and
gastrointestinal symptoms. Respiratory evaluation was performed
to detect respiratory diseases and assess asthma control among
asthma patients (Table 1).
A psychiatrist assessed the presence of psychiatric disorders,
functioning in daily life, and well-being using structured interview
methods and self-assessed measures (Table 1). The psychiatrist
speciﬁed the psychiatric International Classiﬁcation of Diseases,
10th revision (ICD-10) diagnoses after clinical ﬁndings in the psy-
chological assessment including the evaluation of cognitive, social,
and personality functioning and an additional semi-structured vi-
sual expression interview (see supplementary material: Table A.1).
Based on the physician interview, the severity of disability in
social and occupational functioning was scored using the DSM-IV
Social and Occupational Functioning Assessment Scale (SOFAS)
[27].
2.2.3. ANS function and HPA axis functioning
Assessment of the ANS function was included for the evaluation
of physiological stress and recovery processes in laboratory and
real-life settings. We performed cardiovascular tests and the hy-
perventilation provocation test to assess the individual reactivity ofANS and to exclude organic disturbances in autonomic regulation
(Table 1). The cardiac reactivity tests included controlled and un-
controlled breathing, slow deep breathing, the active orthostatic
test, and the sustained hand grip test [34]. Continuous electrocar-
diogram and peripheral blood pressurewere analyzed using special
software for ANS metrics (WinCPRS, Absolute Aliens, Turku,
Finland). Themain indicator of sympathovagal balance in the short-
term provocation tests was the ratio of low-frequency power to
high-frequency power (LF/HF ration) in heart rate variability (HRV)
at rest. A ratio of >2.8 was considered to indicate increased sym-
pathetic dominance [35].
The stress and recovery balance in real-life settings was assessed
using recordings of ReR intervals and analyses of HRV within three
days. In the analyses, we used the recovery percentage during a
sleep period (from self-reported bedtime to awakening time). Re-
cordings of the Finnish population (n ¼ 20 000, including 51 000
days) report themean of recovery time during sleep to be 60% using
HRV analysis [38]. In this study, we used a recovery time of under
60% during sleep as an indicator of delayed recovery.
As an indicator of the HPA axis, we took salivary cortisol samples
three times a day within a two-day period: immediately after
awakening, 30 min after awakening, and in the evening. A range of
3.3e6.1 nmol/L in the salivary evening cortisol level has been re-
ported among the nonanxious population using competitive elec-
trochemiluminescence immunoassay analytics [40]. In this paper,
we report evening analysis, and levels of >6.1 nmol/L were
considered to deviate from the nondistressed population.
2.2.4. IEI deﬁnition
We used WHO’s IEI criteria [13], which cover the acquired
condition with multiple recurrent symptoms attributed to various
environmental factors that are well tolerated by most people and
that cannot be explained by any somatic or psychiatric disorder.
Further, we used the stricter criteria by Lacour et al. [17], which
require a duration of at least six months with signiﬁcant lifestyle or
functional impairments and symptoms to be present in the CNS
with at least one symptom of another organ system.
2.3. Data analysis
We calculated descriptive statistics [frequency, mean, median,
range, and standard deviations (SDs)]. All the statistical analyses
were carried out using SPSS version 25.0 (IBM Corporation, Chi-
cago, Illinois, USA) software.
2.4. Ethical considerations
All procedures performed in the studies involving human par-
ticipants were in accordance with the ethical standards of the
institutional and/or national research committee andwith the 1964
Helsinki declaration and its later amendments or comparable
ethical standards. The Ethics Committee of the Hospital District of
Helsinki and Uusimaa, Finland, approved the study protocol (81/13/
03/00/15, dated 5.5.2015). Permission to conduct the studywas also
granted by the Helsinki University Hospital and the FIOH ethical
working group. All participants provided a written informed con-
sent for participation.
3. Results
Of the 12 recruited patients, two withdrew from part of the
investigations (one because of suffering symptoms at our clinic
facilities and the other due to schedule problems and experiencing
no beneﬁt from the study). Therefore, the number of participants in
Table 2
Demographic characteristics and workplace adjustments made
All (n ¼ 12)
Female, n 11
Age, years, mean (SD) 49.8 (6.0)
Married or cohabitation, n 12
Education
High level, n 6
Mid level, n 3
Basic, n 3
Nonsmoker, n 11
Body mass index, kg/m2, mean (range) 26.9 (21.3e36.3)
Work absence days during preceding 12 months
Owing to any reason, days, mean (range) 92.4 (2e365)
Owing to indoor airerelated symptoms, days, mean (range) 88.6 (0e365)
Physician visits during preceding 12 months
For any reason, number, mean (range) 14.8 (2e40)
For indoor airerelated symptoms, number, mean (range) 13.0 (0e36)
Duration of indoor airerelated symptoms, years (range) 10.5 (2e25)
Workplace adjustmentsa made
Relocation, n 11
Working timetable arrangement, n 1
Sabbatical leave, n 4
Remote work, n 3
Part-time work, n 2
Working as a freelancer in several jobs, n 1
SD, standard deviation.
a An individual may have one or more measures.
Table 3
Self-reported environmental intolerances and concerns, mean (range)
All (n ¼ 12)
QEESI
Chemical Intolerance scorea 50.1 (4e91)
Life Impact scorea 55.5 (1e94)
Intolerance to indoor moldsb 8.7 (0e10)
Intolerance to EMFsb 0.8 (0e6)
Health concerns regarding
Environmental exposuresb 8.8 (3e10)
Indoor air exposures at workplaceb 9.4 (7e10)
EMFs, electromagnetic ﬁelds; QEESI, the Quick Environmental Exposure and
Sensitivity Inventory.
a Sum score 0e100.
b Scale 0e10.
A. Vuokko et al / Disability Related to Indoor Air 365the ANS and HPA axis functioning tests was ten, and that in the
clinical psychiatric evaluation was eleven.
Table 2 presents the demographic data. The ages of the 12 pa-
tients ranged from 39 to 59 years. Most of the patients were female,
highly educated, and nonsmokers. Their workplaces were schools
and kindergartens (n ¼ 8), ofﬁce (n ¼ 2), a hospital (n ¼ 1), and a
ﬁre station (n ¼ 1). The mean of self-reported absence from work
due to indoor airerelated symptoms was 88.6 days (median ¼ 15.5
days, SD 134.6) during the preceding year. At the time of evaluation,
three patients were not working due to symptoms (sick leave or
sabbatical leave).
Based on the clinical interview, the mean duration from onset to
the time when symptoms extended to a disabling level was 7.8
(range 0.5e23) years and from this extension point to the current
evaluation timewas 2.7 (range 1e7) years. All the patients reported
indoor airerelated symptoms from at least three organ systems
(mean 4.5, range 3e6), and all had neurological and respiratory
symptoms.
All the patients reported symptoms attributed to workplace
indoor environments in nonindustrial workplaces, e.g. ofﬁces or
schools. Various deﬁciencies in indoor air quality in previous work
environments, mainlymoisture andmolds, were described bymost
of the patients (n ¼ 10/12). According to the referring physician’s
report, theworkplace facilities had been repaired or theworker had
been relocated. Further, in current work environments, no signiﬁ-
cant exposure or deﬁciency in indoor air quality had been detected
or suspected. For all the 12 patients, one or more occupational
adjustments had been made because of symptoms (Table 2).
Despite interventions, the responsiveness to the triggers in the
work environment had continued in all patients.
Patients perceived the following environmental factors to be the
cause for their current symptoms: indoor molds (n ¼ 10), fra-
grances (n ¼ 1), or both indoor molds and fragrances (n ¼ 1).
Symptoms occurred in various buildings, and/or a wide range of
odorous substances provoked them. Seven patients reported
symptoms when in the vicinity of people who had been in a
moisture-damaged building.In their clinical interviews, the patients reported restraints on
activities imposed by their avoidance behaviors, including work
participation (n¼ 12), attending various places (n¼ 12), socializing
(n ¼ 10), leisure activities (n ¼ 6), and moving or living in con-
ventional homes (n ¼ 3).
3.1. Environmental intolerances and concerns
Chemical intolerance assessed by the QEESI’s CI score indicated
high probability among eight patients (score  40) and low prob-
ability (score  20) among four patients (Table 3). On QEESI’s Life
Impact scale, ten patients showed a high score (score 24e100). In
severity of intolerance to indoor air molds, nine patients scored 10
(scale 0e10), indicating disabling symptoms, and three patients
responded with values of 1, 2, or 6 (scale 0e10) to EMFs (Table 3).
All patients reported considerable environment-related con-
cerns about loss of health (Table 3).
3.2. Self-rated scales of somatic and emotional symptoms
Symptoms were characterized using various self-rated mea-
sures (Table 4; and supplementary material: Table A.2). Six patients
reported insomnia-related symptoms using the Insomnia Severity
Index, and two of these scored moderate or severe insomnia. Eight
patients reported prolonged multisite pain.
3.3. Disability scales
The self-assessment scales indicated a higher severity of
disability than the SOFAS interview tool. The mean of the SOFAS
score (higher scores indicating an increasing level of function) was
78.3 (SD 10.5, range 59e92), indicating a slight impairment, and
scores by tertiles: moderate or some difﬁculty (n ¼ 3), slight
impairment (n ¼ 3), and good or superior functioning (n ¼ 6). On
the inverse SDS (higher scores indicating higher disability), the
mean scores were: SDS work 6.1 (SD 2.7, range 1e10), SDS social life
6.7 (1.9, 4e10), SDS home 4.3 (2.3, 0.5e9), and SDS total (mean of
the three subscales) 5.7 (1.8, 3.7e9.7). All patients scored 5 on at
least one of the three SDS subdomains, indicating signiﬁcant
functional impairment. The mean of the self-assessed current work
ability score [26] was 5.2 (2.4, 0e8). The majority were not sure
(n¼ 8) or hardly sure (n¼ 2) of their ability towork after two years.
3.4. Clinical evaluation
All 12 patients fulﬁlled the IEI criteria in terms of responsiveness
to indoor molds (n ¼ 11), nine of them also reacted to odorous
Table 4
Self-rated symptoms of anxiety, depression, insomnia, and burnout
All (n ¼ 12)
Anxiety GAD-7, mean (range) 4.8 (0e13)
Mild anxiety (score 5e9), n 3
Moderate anxiety (score 10e14), n 3
BAI, mean (range)a 7.0 (0e16)
Mild anxiety (score 8e15), n 4
Moderate anxiety (score 16e25), n 1
OASIS, mean (range)b 3.1 (0e10)
Identiﬁcation of clinical anxiety
(score  8), n
1
Depression PHQ-9, mean (range) 5.0 (0e12)
Mild depression (score 5e9), n 4
Moderate depression (score 10e14), n 2
BDI, mean (range)b 7.2 (1e17)
Mild depression (score 14e19), n 2
Insomnia ISI, mean (range) 9.3 (0e27)
Subthreshold insomnia (score 8e14), n 4
Moderate severity insomnia (score 15
e21), n
1
Severe insomnia (score 22e28), n 1
Burnout SMBM total, mean (range)c 2.9 (1.4e4.6)
Mild or moderate burnout (score 2.3
e3.7), n
5
Severe burnout (score  3.8), n 2
BAI, Beck Anxiety Inventory (sum score 0e63); BDI, Beck Depression Inventory (sum
score 0e63); GAD-7, Generalized Anxiety Disorder (sum score 0e21); ISI, Insomnia
Severity Index (sum score 0e28); OASIS, Overall Anxiety Severity and Impairment
Scale (sum score 0e20); PHQ-9, Patient Health Questionnaire-9 (sum score 0e27);
SMBM, Shirom-Melamed Burnout Measure (score 1e7).
a n ¼ 10.
b n ¼ 11.
c n ¼ 9, three patients who were on sick leave were excluded.
Table 6
Results of investigations of autonomic nervous system function and hypothalamice
pituitaryeadrenal axis functioning, mean (range)
N ¼ 10
Laboratory testing
Rest
Heart rate, bpm 66 (59e69)
Root mean square of successive differences of adjacent
RR-intervals, ms
34 (16e88)
Baroreceptor sensitivity, ms/mmHg 10 (6e17)
Systolic brachial blood pressure, mmHg 129 (100e154)
Diastolic brachial blood pressure, mmHg 80 (70e90)
Active orthostatic test, power of low frequency band to high
frequency band in the spectral analysis of heart rate
variability (LF/HF ratio)
Supine 4.3 (0.7e21.0)
Standing 8.7 (1.0e23.0)
Home monitoring
Heart rate variability in beat-to-beat ReR interval recording
Percentage of recovery during sleep (recovery index)a 56.1 (22.0e89.7)
Salivary cortisol
Evening sample, nmol/Lb 6.2 (1.8e15.9)
a Average of the mean of three values within three days.
b Average of the mean of two different evening samples.
Saf Health Work 2019;10:362e369366chemicals, three to electric devices, and one individual was
responsive to only odorous chemicals.
Ten patients (of 12) had one or more somatic diseases based on
clinical evaluation and medical history (Table 5). Six patients had
asthma, and according to the Asthma Control Test (ACT), asthma
was more often controlled (n ¼ 4, ACT  20) than “not well
controlled” or “uncontrolled” (n ¼ 2, ACT  19). Low lung functionTable 5
Current somatic diseases and psychiatric disorders based on clinical evaluation and
medical history.
Somatic diseasesa N ¼ 12
Asthma 6
Benign arrhythmia 1
Fibromyalgia 1
Hypothyreosis (controlled by medication) 2
Irritable colon syndrome 2
Anal ﬁssure 1
Migraine 2
Musculoskeletal disorder 4
Psychiatric disordersa N ¼ 11
Anxiety disorders
Social phobia 1
Speciﬁed phobic anxiety disorder 1
Other speciﬁed anxiety disorder 4
Reaction to severe stress and adjustment disorder 1
Depressive disorders
Moderate depressive disorder 1
Recurrent depressive disorder, current episode mild 1
Somatoform disorders
Undifferentiated somatoform disorder 1
Somatoform autonomic dysfunction 1
Personality disorders
Obsessive-compulsive personality disorder 1
a An individual may have one or more somatic diseases or psychiatric disorders.in spirometry was detected in none of the asthma patients ac-
cording to forced vital capacity (FVC) or forced expiratory volume in
one second (FEV1) (<80% of the predicted values) or a positive
FEV1% bronchodilator response (12%). There was no excessive
variability in the daily diurnal peak expiratory ﬂow (>10% average
daily variability) or in positive bronchodilator response (15% and
60 L). Some degree of hyperresponsiveness (mild or moderate) was
present in two patients with asthma (of 5, data missing n ¼ 1).
Exhaled nitric oxide was mildly raised (25 ppb) in two patients,
one of whom had asthma. None had positive skin prick test re-
actions to molds. The results of the investigations of allergy and
respiratory tract are shown in supplementary material (Table A.2).
Our evaluation did not reveal any need for additional somatic
investigations.
In eight (of 11) patients, one or more psychiatric disorders were
diagnosed (Table 5). Five patients had one diagnosis and three
patients had two or more. Two patients had previous psychiatric
diagnoses (major depressive disorder, anxiety/phobic anxiety dis-
order, social phobia). Six patients met the diagnostic criteria for an
anxiety disorder according to ICD-10, two of whom also had a
depressive disorder. One patient with anxiety and depressive dis-
orders also had a personality disorder. Another two patients met
the diagnostic criteria for a somatoform disorder.
3.5. Assessment of ANS and HPA axis functioning
Table 6 illustrates the results of ANS and HPA axis functioning
among ten patients. The analysis of the time domain parameters of
HRV showed no changes indicating signiﬁcant clinical cardiovas-
cular disorders. Resting blood pressure was above normal in one
patient. The LF/HF ratio at rest in a supine position was elevated
(>2.8) in three patients, and two of them also showed highest
values while standing. None of the patients showed pathogno-
monic responses in the hyperventilation provocation test.
In a real-life setting, six (of 10) patients showed insufﬁcient
recovery during sleep (recovery index < 60%) in the long-term
monitoring of HRV. Three patients had elevated cortisol levels in
their evening salivary cortisol samples (>6.1 nmol/L). Three pa-
tients had both insufﬁcient recovery in HRV during sleep and an
elevated cortisol level. In total, six patients had either an elevated
LF/HF ratio, insufﬁcient recovery during sleep, or elevated evening
cortisol levels.
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Our study consisted of patients with work disability attributed
to indoor air in nonindustrial work environments. The referring
OHS physician had found no ways in which to intervene in the
worker’s ill health and support work participation. The aim was to
characterize disability in order to better target aid and support
these patients.
The disability manifested in all the 12 patients, as an acquired
long-term state of responsiveness to the indoor work environment,
which patients attributed to indoor pollutants, mainly molds. In
their current work environments evoking symptoms, there was no
evidence of or suspicion of harmful indoor exposures. Self-
assessment and a physician interview tool assessing disability
showed that the patients had functional impairments not only at
work but also at home and in their social lives. The questionnaire
revealed that insomnia-related symptoms (in 6 of 12) and multisite
pain (in 8 of 12) were prevalent. ANS or cortisol measurements
were elevated in some (in 6 of 10). No medical cause was found to
explain the disability, although the patients had somatic diseases
such as asthma and psychiatric disorders. Based on our results, the
features of disability were consistent with those described in IEI
and FSSs.
All our patients fulﬁlled the WHO consensus criteria for IEI [13].
They also met the MCS criteria [16], in which exposures are
expanded from chemicals to indoor exposures. All had signiﬁcant
functional and lifestyle impairments which are required by the
extended MCS criteria [17]. Our patients were similar to those
described in several reviews on IEI [7,18,52]. Almost all the patients
were women and had multiorgan symptoms, including CNS, and
respiratory symptoms triggered by ordinary indoor environments
with no known health risks, restrictions in everyday life, and co-
morbidity of diseases. Negative beliefs and high concerns regarding
the impact of exposure on health were also prevalent among our
patients, as described earlier [11,53]. As inherent to IEI [14], we did
not ﬁnd toxicological causes to explain disability. Symptoms had
continued despite actions taken in workplaces and the absence of
abnormal exposure in the patients’ current work environments.
Features of prolongedmultiple symptoms, (work) disability, and
the co-occurrence of variable health conditions with no explana-
tory medical condition appear as manifestations of FSSs [54].
Lacour et al. [17] summarize the overlap between IEI and FSSs, and
sharedmechanisms have been suggested for the maintenance of IEI
and FSSs, i.e., sustained stress and arousal due to central sensiti-
zation [55]. The increasing evidence of central mechanisms of
chronic responsiveness [11] enables targeting treatment strategies
to reduce disability.
Our patients had long-lasting symptoms in multiple organ
systems, which have shown to associate with poor prognosis in
previous clinical samples [2,3]. A study by Baliatsas et al. [56] has
also shown that in IEI to electric devices, an increasing number and
duration of nonspeciﬁc symptoms associate with increased func-
tional impairments and illness behaviors. Our study showed a
gradual exacerbation and increase of symptom spectrum and
functional impairments. We also saw a spreading of responsiveness
to other triggers in our patients, which is a typical feature of IEI
[11,18]. In addition to indoor molds, symptom triggers also included
odorous chemicals and electric devices. This kind of overlap with
building-related ill health and other IEIs has previously been seen
in very few clinical materials [2,10] and in questionnaire-based
studies [20,57]. In our study, we used the QEESI to identify chem-
ical intolerance and avoidance behavior. To identify indoor air and
EMF-related intolerance, we formed additional questions analo-
gous to the QEESI. The instruments supported the information
gained by clinical history.Disability in IEI is based on self-reporting of symptoms and
limitations in everyday functioning [7,17]. The subjective SDS
assessment tool showed functional impairments in activities and
participation in the varying domains of work, social life, and home
functioning. The restraints in functional areas of everyday life were
due to individual situation-bounded avoidance behavior due to
symptom triggers in certain surroundings. The self-assessed (SDS
and work ability score) function related to the psychosocial (ac-
tivity and participation) environments indicated higher severity of
disability than the physician assessment using the SOFAS interview
tool. A recent study of psychiatric patients at a tertiary outpatient
clinic [58] did not ﬁnd this disparity between subjective (SDS) and
physician (SOFAS) measures of function. This may reﬂect the nature
of perceived suffering in IEI. Patients with IEI often report not being
taken seriously by others and that their suffering is not recognized
by healthcare professionals [10].
Most of our patients met the ICD-10 criteria for at least one
psychiatric disorder, mainly an anxiety disorder. Psychiatric co-
morbidity has previously received little attention in indoor aire
related disability, although high psychiatric comorbidity has been
seen in patients with MCS/IEI (e.g. [21]). The self-reported psychi-
atric symptoms were quite modest, which may reﬂect patients’
resistance to psychological and psychiatric labels [7,59].
Somatic comorbidity, such as asthma, has also been shown in
previous studies of IEI (e.g. [22]). A half of our patients had asthma,
and in all of them, it was well controlled by objective measure-
ments. It should, however, be noted that, as ACT is based on self-
assessed symptoms, it may exaggerate the noncontrol of asthma
due to overlapping IEI symptoms [5]. After a thorough examination,
neither somatic nor psychiatric disorder could be identiﬁed as the
major cause of the disabling symptoms. However, psychiatric cau-
ses may have contributed to disability. Comorbidity must be
recognized because treating other conditions may reduce disability.
The patients reported insomnia-related symptoms andmultisite
pain, which have also been reported in some previous studies
among MCS patients [23,59] and are a typical feature of FSSs
[60,61]. In addition, our patients reported work-related burnout on
facets of physical, cognitive, and emotional functioning. Burnout
typically co-occurs with distress disorders such as impaired sleep,
pain, and anxiety [62,63]. Various underlying health conditions and
psychosocial load affecting function and well-being may not
necessarily be recognized if they are not systematically elicited.
Recognition enables various stress-reducing interventions in
disability.
The physiological stress and arousal indicators of ANS and HPA
axis functioning showed varying results. We did detect a tendency
of insufﬁcient recovery in HRV recording and raised evening
cortisol levels but found no speciﬁc proﬁle in the ANS or HPA axis
function. Physiological measurements do not always necessarily
correspond with symptoms and their severity [64].
The preponderance of indoor molds as a trigger of IEI may be
explained by the general concern that indoor molds are an envi-
ronmental health hazard in Finland. In a recent study, 11.4% of a
sample of working-aged people perceived their workplaces’ indoor
environments as harmful due to molds [65]. Another Finnish study
among pregnant women attributed the most severe cases of envi-
ronmental intolerance to indoor molds [20]. Cultural and societal
factors may also contribute to IEI. The differences between the
environmental factors to which IEI is attributed in different coun-
tries reﬂect the risk perceptions of the population [66].
The strengths of this study were its thorough multiprofessional
clinical evaluation and the use of validated and widely used in-
struments. Its limitation was the small number of patients, which
restricts generalization of the results. In addition, participants who
were more able to consider their condition from a biopsychosocial
Saf Health Work 2019;10:362e369368point of view may have been selected. As this study was a case
series of 12 patients, we did not include control groups, such as
healthy controls or other disease groups, which can also be seen as
a limitation. Previously, indoor airerelated disability has not been
sufﬁciently characterized; thus, the current clinical series is
valuable.5. Conclusions
The studied indoor airerelated disabling condition seems to be a
form of IEI. We found co-occurring somatic and psychiatric di-
agnoses and signs of distress but no medical disease to explain
disability. The ﬁndings in our patients and in IEI, in general, are
typical to FSSs. Recognition of IEI enables FSS interventions to
support recovery and reduces the need to continuously search for
medical and environmental explanations.Conﬂicts of interest
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